Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions

American Journal of Cardiology

Volumn 109, Issue 11, 2012, Pages 1563-1568

  Assali, Abid ^a   Vaduganathan, Muthiah ^b   Vaknin Assa, Hanna ^a   Lev, Eli I ^a   Brosh, David ^a   Teplitsky, Igal ^a   Bental, Tamir ^a   Battler, Alexander ^a   Kornowski, Ran ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL; UMIROLIMUS; ZOTAROLIMUS;

ADULT; ARTICLE; BARE METAL STENT; CARDIAC PATIENT; CONTROLLED STUDY; DISEASE REGISTRY; DRUG ELUTING STENT; EMERGENCY SURGERY; FEMALE; HEART MUSCLE REVASCULARIZATION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SURVIVAL;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY STENOSIS; CORONARY THROMBOSIS; DIABETES MELLITUS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROPENSITY SCORE; PROSPECTIVE STUDIES; RECURRENCE; REGISTRIES; RENAL INSUFFICIENCY; RETREATMENT; STENTS;

EID: 84861202809     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.01.378     Document Type: Article

References (16)

1. B.R. Brodie, T. Stuckey, W. Downey, A. Humphrey, M. Nussbaum, S. Laurent, B. Bradshaw, C. Metzger, J. Hermiller, F. Krainin, S. Juks, B. Cheek, P. Duffy, C.A. Simonton Strategic Transcatheter Evaluation of New Therapies (STENT) Group Outcomes with drug-eluting stents versus bare metal stents in acute ST-elevation myocardial infarction: results from the Strategic Transcatheter Evaluation of New Therapies (STENT) group Catheter Cardiovasc Interv 72 2008 893 900
2. E.L. Hannan, M. Racz, G. Walford, D.R. Holmes, R.H. Jones, S. Sharma, S. Katz, S.B. King III Drug-eluting versus bare-metal stents in the treatment of patients with ST-segment elevation myocardial infarction JACC Cardiovasc Interv 1 2008 129 135
3. A. Kaltoft, L.O. Jensen, M. Maeng, H.H. Tilsted, P. Thayssen, M. Bottcher, J.F. Lassen, L.R. Krusell, K. Rasmussen, K.N. Hansen, L. Pedersen, S.P. Johnsen, H.T. Sorensen, L. Thuesen 2-Year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry) J Am Coll Cardiol 53 2009 658 664
4. P.A. Lemos, F. Saia, S.H. Hofma, J. Daemen, A.T. Ong, C.A. Arampatzis, A. Hoye, E. McFadden, G. Sianos, P.C. Smits, W.J. van der Giessen, P. de Feyter, R.T. van Domburg, P.W. Serruys Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction J Am Coll Cardiol 43 2004 704 708
5. L. Mauri, T.S. Silbaugh, P. Garg, R.E. Wolf, K. Zelevinsky, A. Lovett, M.R. Varma, Z. Zhou, S.L. Normand Drug-eluting or bare-metal stents for acute myocardial infarction N Engl J Med 359 2008 1330 1342
6. P.G. Steg, K.A. Fox, K.A. Eagle, M. Furman, F. Van de Werf, G. Montalescot, S.G. Goodman, A. Avezum, W. Huang, J.M. Gore Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Eur Heart J 30 2009 321 329
7. B. Pierre-Louis, W.S. Aronow, C. Palaniswamy, T. Singh, C. Ahn, A. Asija, M.B. Weiss, K. Kalapatapu, A.L. Pucillo, C.E. Monsen Major adverse cardiac events at follow-up after bare-metal stenting versus drug-eluting stenting in ST-elevated myocardial infarction Am J Cardiol 103 2009 1672 1674
8. G. Campo, F. Saia, G. Percoco, A. Manari, A. Santarelli, L. Vignali, E. Varani, A. Benassi, P. Sangiorgio, F. Tarantino, P. Magnavacchi, R. De Palma, P. Guastaroba, A. Marzocchi Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry Int J Cardiol 140 2010 154 160
9. J.C. George, G.D. Dangas 2009 focused updates to guidelines in ST-elevation myocardial infarction and percutaneous coronary intervention: application to interventional cardiology JACC Cardiovasc Interv 3 2010 256 258
10. E.A. Stuart Matching methods for causal inference: a review and a look forward Stat Sci 25 2010 1 21
11. P.R. Rosenbam, D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1985 41 55
12. R.J. Little, D.B. Rubin Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches Annu Rev Public Health 21 2000 121 145
13. A. Halkin, M. Singh, E. Nikolsky, C.L. Grines, J.E. Tcheng, E. Garcia, D.A. Cox, M. Turco, T.D. Stuckey, Y. Na, A.J. Lanksy, B.J. Gersh, W.W. O'Neill, R. Mehran, G.W. Stone Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score J Am Coll Cardiol 45 2005 1397 1405
14. M.A. Vink, M.T. Dirksen, M.J. Suttorp, J.G. Tijssen, J. van Etten, M.S. Patterson, T. Slagboom, F. Kiemeneij, G.J. Laarman 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial JACC Cardiovasc Intverv 4 2011 24 29
15. A. Dibra, K. Tiroch, S. Schulz, H. Kelbaek, C. Spaulding, G.J. Laarman, M. Valgimigli, E. Di Lorenzo, C. Kaiser, I. Tierala, G. Campo, L. Thuesen, M.A. Vink, M.J. Schalij, R. Violini, A. Schomig, J. Mehilli, A. Kastrati Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials Clin Res Cardiol 99 2010 345 357
16. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, M. Fahy, H. Parise, R. Mehran HORIZONS-AMI Trial Investigators Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial Lancet 377 2011 2193 2204